Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Timber Pharmaceuticals Inc (TMBR)

Timber Pharmaceuticals Inc (TMBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Timber Pharmaceuticals Inc 3 Mountain View Road Suite 100 Warren NJ 07059 USA

www.timberpharma.com P: 973-314-9577

Description:

Timber Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on the development and commercialization of treatments for orphan dermatologic diseases. The Company is initially engaged on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis, tuberous sclerosis complex and localized scleroderma. Timber Pharmaceuticals Inc., formerly known as BioPharmX Corporation, is based in NJ, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,176
Enterprise Value, $K -7,904
Shares Outstanding, K 3,433
Annual Sales, $ 80 K
Annual Net Income, $ -19,380 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,060 K
EBIT, $ -14,700 K
EBITDA, $ -14,370 K
60-Month Beta 0.03
% of Insider Shareholders 1.61%
% of Institutional Shareholders 3.62%
Float, K 3,377
% Float 98.39%
Short Volume Ratio 0.46

Growth:

1-Year Return -74.03%
3-Year Return -99.40%
5-Year Return -99.98%
5-Year Revenue Growth 14.29%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.27 on 08/21/23
Next Earnings Date 12/04/23
Earnings Per Share ttm -4.11
EPS Growth vs. Prev Qtr 3.79%
EPS Growth vs. Prev Year 71.78%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 11/09/22

TMBR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -511.45%
Return-on-Assets % -180.93%
Profit Margin % -24,225.00%
Debt/Equity 0.00
Price/Sales 14.07
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.86
Interest Coverage -83.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar